Seattle, WA — (SBWIRE) — 09/13/2017 — The report “Fluoroscopy Equipment Market by Product (Fixed Fluoroscopy Equipment (Remote Controlled, Conventional), C-arms), Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular)) and Region – Global Forecast to 2022″, the global fluoroscopy equipment market is projected to reach USD 2.79 Billion by 2022 from USD 2.21 Billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include the advantages of FPDs over image intensifiers, growing popularity of multipurpose imaging systems, use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, increasing demand for minimally invasive procedures, growing geriatric population, and the rising prevalence of chronic diseases.
Browse 65 Market Data Tables and 39 Figures spread through 141 Pages and in-depth TOC on “Fluoroscopy Equipment Market”
Early buyers will receive 10% customization on this report.
By product, the fixed fluoroscopy segment accounted for the largest share of the market in 2017
On the basis of product, the fluoroscopy equipment market is broadly segmented into fixed fluoroscopy equipment and C-arms. In 2017, the fixed fluoroscopy equipment segment is expected to account for the largest share of this market owing to the increasing use of fluoroscopy in diagnostic imaging across various application areas like cardiology, gastroenterology, and urology. The fixed fluoroscopy equipment segment is further segmented into remote-controlled fluoroscopy systems and conventional fluoroscopy systems. The remote-controlled fluoroscopy systems segment accounted for the largest share and highest CAGR of the fixed fluoroscopy equipment market in 2016.
To know about the assumptions considered for the study, download the pdf [email protected]
By application, the diagnostic application segment held the largest market share in 2017
Based on application, the market is segmented into diagnostic applications and surgical applications. The diagnostic applications segment is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology). The cardiology segment is estimated to command the largest share of the fluoroscopy equipment market for diagnostic applications. The large share and high growth of this segment can be attributed to the rising geriatric population, increasing prevalence of cardiovascular diseases (CVDs), and the wide use of fluoroscopic imaging in the diagnosis and treatment of various cardiac conditions.
To speak to our analyst for a discussion on the above findings, [email protected]
North America dominated the market in 2017
North America accounted for the largest share of the fluoroscopy equipment market in 2017, followed by Europe, Asia Pacific (APAC) and the Rest of the World (Latin America and the Middle East and Africa). Factors such as increasing incidence of overuse sports injuries, rising prevalence of CVDs, and increasing number of hip and knee replacement surgeries in the region are contributing to the large share of North America. The fluoroscopy equipment market in several APAC countries, particularly China, Japan, India, and ASEAN countries, is expected to witness high growth during the forecast period. This can be attributed to the significant growth in the prevalence of CVDs in these countries. With the growing severity of disease conditions, the demand for fluoroscopy equipment and C-arms in this regional segment is also expected to increase significantly.
The key players in the global fluoroscopy equipment market are Siemens AG (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
Email: [email protected]
Powered by WPeMatico